Suplementos de venta libre y salud cardiovascular: posicionamiento del Comité del Cardiólogo Joven de la Federación Argentina de Cardiología
DOI:
https://doi.org/10.63600/30n1kc04Palabras clave:
Suplementos, Colágeno, Magnesio, Vitamina C, Zinc, Salud cardiovascularResumen
La enfermedad cardiovascular sigue siendo la principal causa de muerte en Argentina, lo que subraya la importancia de reforzar las medidas preventivas basadas en hábitos saludables. En paralelo, el consumo de suplementos dietarios ha aumentado de manera significativa, impulsado por redes sociales, marketing y la disponibilidad de productos de venta libre, pese a la falta de control riguroso sobre su composición. Aunque muchos suplementos se promocionan como beneficiosos para la salud cardiovascular o el rendimiento físico, la evidencia científica que respalda estas afirmaciones es limitada y, en algunos casos, se desconocen sus efectos en pacientes con enfermedad cardiovascular establecida o bajo tratamientos específicos. Ante este panorama, el Comité del Cardiólogo Joven de la Federación Argentina de Cardiología considera necesario emitir una postura para fomentar una prescripción basada en evidencia.
Referencias
(1) Natalidad y Mortalidad 2022 – Síntesis estadística DEIS N° 9. Ministerio de Salud Argentina. Buenos Aires, mayo de 2024.
(2) Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021 Sep 7;42(34).
(3) Mishra S, Stierman B, Gahche JJ, Potischman N. Uso de suplementos dietéticos en adultos: Estados Unidos, 2017-2018. Resumen de datos del NCHS, n.° 399. Hyattsville, MD: Centro Nacional de Estadísticas de Salud. 2021.
(4) O'Connor EA, Evans CV, Ivlev I, Rushkin MC, Thomas RG, Martin A, et al. Vitamin and Mineral Supplements for the Primary Prevention of Cardiovascular Disease and Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2022;327(23):2334–2347.
(5) Alcaide-Ruggiero L, Molina-Hernández V, Granados M, Domínguez J. Main and Minor Types of Collagens in the Articular Cartilage: The Role of Collagens in Repair Tissue Evaluation in Chondral Defects. Int. J. Mol. Sci. 2021, 22, 13329.
(6) Olabiyi A, de Castro Braz L. Cardiovascular Ischemia: Advancement and Potential Use of Collagen-Based Therapeutic Strategies. Int. J. Mol. Sci. 2025, 26, 9275.
(7) Jalili Z, Jalili F, Moradi S, Bagheri R, Moosavian SP, Naeini F, et al. Effects of collagen peptide supplementation on cardiovascular markers: a systematic review and meta-analysis of randomised, placebo-controlled trials. Br J Nutr. 2023;129(5):779-794.
(8) Guan Y, Dai P, Wang H. Effects of vitamin C supplementation on essential hypertension: A systematic review and meta-analysis. Medicine. Baltimore. 2020 Feb;99(8):19274.
(9) Gegotek A, Skrzydlewska E. Antioxidative and anti-inflammatory activity of ascorbic acid. Antioxidants (Basel). (2022) 11:1993.
(10) Ran L, Zhao W, Tan X, Wang H, Mizuno K, Takagi K, et al. Association between Serum Vitamin C and the Blood Pressure: A Systematic Review and Meta-Analysis of Observational Studies. Cardiovasc. Ther. 2020. 4940673.
(11) Moser MA, Chun OK. Vitamin C and Heart Health: A Review Based on Findings from Epidemiologic Studies. Int J Mol Sci. 2016 Aug 12;17(8):1328.
(12) Morelli MB, Gambardella J, Castellanos V, Trimarco V, Santulli G. Vitamin C and Cardiovascular Disease: An Update. Antioxidants (Basel). 2020 Dec 3;9(12):1227.
(13) Ashor A, Lara J, Mathers J, Siervo M. Effect of vitamin C on endothelial function in health and disease: A systematic review and meta-analysis of randomised controlled trials. Atherosclerosis. 2014;235:9–20.
(14) Ye Z, Song H. Antioxidant vitamins intake and the risk of coronary heart disease: Meta-analysis of cohort studies. Eur. J. Cardiovasc. Prev. Rehabil. 2008;15:26–34.
(15) Al-Khudairy L, Flowers N, Wheelhouse R, Ghannam O, Hartley L, Stranges S, et al. Vitamin C supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2017 Mar 16;3(3):CD011114.
(16) Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA. 2008 Nov 12;300(18):2123-33.
(17) Ashor AW, Brown R, Keenan PD. Limited Evidence for a Beneficial Effect of Vitamin C Supplementation on Biomarkers of Cardiovascular Diseases: An Umbrella Review of Systematic Reviews and Meta-Analyses. Nutrition Research (New York, N.Y.). 2019;61:1-12.
(18) Jenkins DJA, Spence JD, Giovannucci EL, Kim YI, Josse RG, Vieth R, et al. Supplemental Vitamins and Minerals for Cardiovascular Disease Prevention and Treatment: JACC Focus Seminar. J Am Coll Cardiol. 2021 Feb 2;77(4):423-436.
(19) Hara T, Yoshigai E, Ohashi T, Fukada T. Zinc in Cardiovascular Functions and Diseases: Epidemiology and Molecular Mechanisms for Therapeutic Development. Int J Mol Sci. 2023 Apr 12;24(8):7152.
(20) Rubio C, González Weller D, Martín-Izquierdo R, Revert C, Rodríguez I, Hardisson A. Zinc: an essential oligoelement. C. Nutr. Hosp. 22 (1). 2007.
(21) Nazari M, Ashtary-Larky D, Nikbaf-Shandiz M, Goudarzi K, Bagheri R, Dolatshahi S, et al. Zinc supplementation and cardiovascular disease risk factors: A GRADE-assessed systematic review and dose-response meta-analysis. J Trace Elem Med Biol. 2023. (79):127244.
(22) Khazdouz M, Djalalinia S, Sarrafi Zadeh S, Hasani M, Shidfar F, Ataie-Jafari A, et al. Effects of Zinc Supplementation on Cardiometabolic Risk Factors: a Systematic Review and Meta-analysis of Randomized Controlled Trials. Biol Trace Elem Res. 2020 Jun;195(2):373-398.
(23) Pompano LM, Boy E. Effects of Dose and Duration of Zinc Interventions on Risk Factors for Type 2 Diabetes and Cardiovascular Disease: A Systematic Review and Meta-Analysis. Adv Nutr. 2021 Feb 1;12(1):141-160.
(24) Ranasinghe P, Wathurapatha WS, Ishara MH, Jayawardana R, Galappatthy P, Katulanda P, et al. Effects of Zinc supplementation on serum lipids: a systematic review and meta-analysis. Nutr Metab (Lond). 2015 Aug 4;12:26.
(25) Nazari M, Nikbaf-Shandiz M, Pashayee-Khamene F, Bagheri R, Goudarzi K, Hosseinnia NV, et al. Zinc Supplementation in Individuals with Prediabetes and type 2 Diabetes: a GRADE-Assessed Systematic Review and Dose-Response Meta-analysis. Biol Trace Elem Res. 2024 Jul;202(7):2966-2990.
(26) Chu A, Foster M, Samman S. Zinc Status and Risk of Cardiovascular Diseases and Type 2 Diabetes Mellitus-A Systematic Review of Prospective Cohort Studies. Nutrients. 2016 Nov 5;8(11):707.
(27) Pérez Navarro P, Martos Anguita E, Jiménez-Navarro M, Gutiérrez-Bedmar M. Niveles de magnesio y enfermedad cardiovascular: revisión sistemática y metanálisis. REC: CardioClinics. 2021;56(3):179-189.
(28) Tangvoraphonkchai K, Davenport A. Magnesium and Cardiovascular Disease. Adv Chronic Kidney Dis. 2018;25(3):251-260.
(29) Nielsen FH. Dietary Magnesium and Chronic Disease. Adv Chronic Kidney Dis. 2018;25(3):230-235.
(30) Alimentos con magnesio fáciles de añadir a la dieta. Academia española de nutrición y dietética. Diciembre, 2024.
(31) Qu X, Jin F, Hao Y, Li H, Tang T, Wang H, et al. Magnesium and the risk of cardiovascular events: a meta-analysis of prospective cohort studies. PLoS One. 2013;8(3):e57720.
(32) Del Gobbo LC, Imamura F, Wu JHY, De Oliveira Otto MC, Chiuve SE, Mozaffarian D. Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr. 2013;98(1):160-173.
(33) Wu J, Xun P, Tang Q, Cai W, He K. Circulating magnesium levels and incidence of coronary heart diseases, hypertension, and type 2 diabetes mellitus: a meta-analysis of prospective cohort studies. Nutr J. 2017;16(1):60.
(34) Chiuve SE, Sun Q, Curhan GC, Taylor EN, Spiegelman D, Willett WC, et al. Dietary and plasma magnesium and risk of coronary heart disease among women. J Am Heart Assoc. 2013 Mar 18;2(2):e000114.
(35) Chiuve SE, Korngold EC, Januzzi JL, Gantzer M Lou, Albert CM. Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr. 2011;93(2):253-260.
(36) Cheng Y, Zullo AR, Yin Y, Shao Y, Liu S, Zeng-Treitler Q, et al. Nonprescription Magnesium Supplement Use and Risk of Heart Failure in Patients With Diabetes: A Target Trial Emulation. J Am Heart Assoc. 2025 Apr;14(7):e038870.
(37) Rosique-Esteban N, Guasch-Ferré M, Hernández-Alonso P, Salas-Salvadó J. Dietary Magnesium and Cardiovascular Disease: A Review with Emphasis in Epidemiological Studies. Nutrients 2018, Vol 10, Page 168. 2018;10(2):168.
